Mr. Ronald J Sherman, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3409 Ludington Street, Suite 203, Escanaba, MI 49829 Phone: 906-789-4427 Fax: 906-789-4446 |
News Archive
People who are blind from birth are able to detect tactile information faster than people with normal vision, according to a study in the Oct. 27 issue of The Journal of Neuroscience.
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.
Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").
Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
As GOP lawmakers and health law critics gloat, administration officials say they are listening to concerns from business and being flexible.
› Verified 8 days ago